Psilocybin for obsessive-compulsive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 4 registered trials.

Why this status

  1. 4 Oct 2017: Trial registered, NCT03300947
  2. 29 Nov 2017: Trial registered, NCT03356483
  3. 13 Nov 2018: Trial started, NCT03356483
  4. 2 Jan 2019: Trial started, NCT03300947
  5. 12 May 2022: Trial registered, NCT05370911
  6. 20 Jul 2023: Trial started, NCT05370911
  7. 7 Mar 2024: Trial registered, NCT06299319
  8. 1 Sep 2024: Trial started, NCT06299319

The trials

NCT03300947: Psilocybin for Treatment of Obsessive Compulsive Disorder

State
Completed
Phase
Phase 1
People
15 taking part
Started
2 Jan 2019
Primary completion
30 Oct 2023
Arms
High- or Low-dose Psilocybin
Results
None posted
Papers
doi:10.1177/02698811261424214, doi:10.4088/jcp.v67n1110
  1. 4 Oct 2017: Trial registered
  2. 2 Jan 2019: Trial started
  3. 30 Dec 2023: Trial completed

NCT03356483: Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

State
Completed
Phase
Phase 1
People
28 taking part
Started
13 Nov 2018
Primary completion
25 Jul 2024
Arms
Psilocybin
Results
Posted on the registry
Papers
doi:10.3389/fpsyt.2023.1178529
  1. 29 Nov 2017: Trial registered
  2. 13 Nov 2018: Trial started
  3. 25 Jul 2024: Trial completed
  4. 16 Oct 2026: Trial results posted

NCT05370911: Effects of Repeated Psilocybin Dosing in OCD

State
Under way
Phase
Phase 1
People
28 taking part
Started
20 Jul 2023
Primary completion
17 Feb 2026
Arms
Immediate Treatment
Results
None posted
Papers
doi:10.3389/fpsyt.2023.1278823
  1. 12 May 2022: Trial registered
  2. 20 Jul 2023: Trial started

NCT06299319: Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD

State
Completed
Phase
Phase 1
People
10 taking part
Started
1 Sep 2024
Primary completion
4 Sep 2026
Arms
Experimental: Psilocybin 25 mg
Results
None posted
  1. 7 Mar 2024: Trial registered
  2. 1 Sep 2024: Trial started
  3. 4 Sep 2026: Trial completed

How the status changed

  1. 16 Nov 2026: First set: Phase 1 trial

About the treatment

Also known as High Dose Psilocybin, Low Dose Psilocybin, Medium Dose Psilocybin, Psilocybin (0.25mg/kg), Psilocybin (Usona Institute), Psilocybin (drug), Psilocybin 100 mcg/kg, Psilocybin 25 mg, Psilocybin 25 mg per os, Psilocybin 25mg, Psilocybin assisted therapy, Psilocybin first, Psilocybin plus Visual Healing Set and Setting, Psilocybin therapy, psilocybin 25 mg sod.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.